Friday 1 May 2020

New Study of Diabetes Drug for COVID-19 Raises Eyebrows

Some question the safety of AstraZeneca's just-launched DARE-19 study testing whether the type 2 diabetes drug dapagliflozin will reduce adverse outcomes of COVID-19.



from WebMD Health https://ift.tt/2yhv09Y

0 comments:

Post a Comment